GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pentixapharm Holding AG (XTER:PTP) » Definitions » FFO

Pentixapharm Holding AG (XTER:PTP) FFO


View and export this data going back to 2024. Start your Free Trial

What is Pentixapharm Holding AG FFO?

FFO (Funds from operations) only applies to REITs.


Pentixapharm Holding AG Business Description

Traded in Other Exchanges
N/A
Address
Robert-Rossle-Street 10, Berlin, DEU
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic.